BrightEdge — Full Portfolio

Alpheus is a clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMA™), a drug-led oncology approach designed to treat glioblastoma using proprietary low-intensity ultrasound to activate tumor-localized porphyrin metabolites.

BiotechHealthtechMedical DevicesChanhassen, US

Jeremy Ling(Executive Officer)inSteve Weiner(Executive Officer)Vijay Agarwal(Founder, President and CEO)inWilliam Davis(Executive Officer, Director)

BoardKVKlaus Veitinger(Director)inIEImran Eba(Executive Officer)in

Co-investorsOROrbiMedHEHealthQuest CapitalSASamsara BioCapitalSVSV Health InvestorsACAction Potential Venture Capital Ltd.

The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities.

Digital HealthHealthtechImpact & Social Good

Co-investorsBLBlue Ledge CapitalFRFred Hutchinson Cancer Research Center

BiotechNewton, US

Katharine Yen(Executive Officer, Director)KYKate Yen(Founder)inChristopher Guiffre(Executive Officer)

BoardAlon Lazarus(Director)AFAnna French(Director)inACAlexandra Cantley(Director)in

Co-investorsDCDCVC (Data Collective)QIQiming Venture Partners USAAPApollo Health VenturesDCDCVC BioPOPolaris PartnersQIQiming Venture Partners

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

MLMarco Lobba(Founder)inMatthew Francis(Founder)in

Co-investorsCACALIFORNIA INNOVATIONCICivilization Ventures Management, LlcCRCreative Destruction Lab (CDL)FRFREEFLOWIAIaso VenturesJUJude Gomila+14 more

CellCentric develops inobrodib, a small-molecule oral p300/CBP inhibitor intended to treat multiple myeloma and other cancers.

BiotechHealthtechMedical Devices

Azim Surani(Co-founder)

Co-investorsAVAvego BioScience CapitalFUFuture Planet CapitalHBHBM Healthcare InvestmentsHBHBM PartnersRARA CapitalSOSofinnova Partners+3 more

Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLАre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.

BiotechHealthtechCambridge, US

Co-investorsCACatalio Capital Management, LPCUCure VenturesVIVivo CapitalCACatalio Capital ManagementNONovo HoldingsTHThird Rock Ventures

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLBLaura Brass(Director)inKWKai Wucherpfennig(Director)

Co-investorsAGAgent CapitalDCDC Investment PartnersLILifelinkLOLongwood FundMEMedical Excellence CapitalNONovartis Venture Fund+5 more

BiotechPhiladelphia, US

Philip R. Johnson, M.D.(Executive Officer, Director)inDora Mitchell(Executive Officer)LFLori Forrest(Executive Officer)Leon Moulder, Jr.(Director)BLBenjamin Lund(Director)in

BoardTomas Kiselak(Director)

Co-investorsAGAgent CapitalDCDC Investment PartnersLOLongwood FundOUOUP (Osage University Partners)PFPfizer Venture InvestmentsQUQuan Capital+4 more

Lunit develops AI-powered cancer diagnostics and biomarker analysis tools used by hospitals and biopharmaceutical companies.

AI & Machine LearningHealthtechMedical Devices

APAnthony Paek(Founder)inAnthony Seungwook Paek(Founder)Brandon Beomseok Suh(Founder)

Co-investorsATAtinum Investment Co. Ltd.GRGroom InvestmentIMIMM Investment JapanKAKakao VenturesKTKT investment Inc.KTKT Strategic Investment Fund 4+2 more

Machine learning and data platform for understanding how diseases fight back and resist therapies

DLDavid Li(Founder)in

Co-investorsHAHAWKTAILJUJude GomilaVAValkyrieAXAxial VCHOHOF CapitalOBObvious Ventures+3 more

Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.

BiotechDigital HealthHealthtechMedical DevicesNatick, US

Paul Blavin(Co-Founder & Vice Chairman)inSLStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)

BoardPMPaul Meister(Director)SHSonja Hoel Perkins(Director)in

Co-investorsAVAvestria VenturesHAHatteras Venture PartnersISiSelect FundMIMindshift CapitalNONovalis LifeSciencesPOPortfolia+2 more

Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.

BiotechHealthtechNew Haven, US

RBRanjit Bindra(Director)inKingson Lin(Cofounder)inKLKevin L. Rakin(Executive Officer, Director)in

BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)

Co-investorsCOConnecticut InnovationsHIHighCape CapitalPAPathway BioventuresADAdvantage Capital PartnersIRIronwood Capital

Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US

JMJames McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)

BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)

Co-investorsGUGurnet Point CapitalTETechU Ventures

Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications.

BiotechDeep TechHealthtechMedical DevicesWest Valley City, US

Howard C. Lewin(Co-founder & Chief Product Development Officer)inGlenn B. Rosenthal(Co-founder & Chief Technology Officer)in

Co-investorsWAWasatch Equity PartnersSESection 32S3S32

Paradigm is a technology investment firm that backs founders across stages in areas including cryptocurrency, artificial intelligence, robotics, and other frontier technologies.

AI & Machine LearningCrypto & Web3Data & InfrastructureRobotics

MHMatt Huang(Founder)inAMAnna Monaco(Founder)inAnna Monaco June Lee(Founder)Fred Ehrsam(Founder)June Lee(Founder)Michael Alfano(Founder)

Co-investorsBABalaji SrinivasanMEMetastableDODorm RoomDRDragonflyEMEmles Venture PartnersFAFailup Ventures+2 more

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSColumbus, US

KTKent Thoelke(Founder)inJonathan Hirsch(Chief Strategy and Growth Officer)JTJay Trepanier(Chief Financial Officer)inElijah Meerson(Chief Technology Officer)inMLMichelle Lee(Chief Operating Officer)in

Co-investorsARARCH Venture PartnersGEGeneral CatalystGVGV (Google Ventures)LULux CapitalF-F-Prime CapitalJOJobsOhio Ventures+2 more

TailorMed provides a platform that helps patients access, afford, and stay on their prescribed medications by connecting them to financial assistance and support programs.

Digital HealthHealthtechSaaS

ASAdam Siton(Founder)inI(Israel (Srulik) Dvorsky(Founder)in

Co-investorsACAccelmed PartnersALAllumia VenturesBABallad VenturesBRBridges IsraelOSOSF VenturesSASamsung Next+3 more

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.

BiotechDeep TechHealthtechSan Francisco, US

LHLaura Hsieh(Founder & CEO)in

Co-investorsFRFREEFLOWEMEmpath VenturesSASazzeSOSOSVSTStoryHouseXEXEIA Venture Partners

Wellness & FitnessBoston, US

Co-investorsALAlumni VenturesAMAmerican Family Insurance Institute for Corporate and Social ImpactCECeltic House Asia PartnersFLFlare Capital PartnersHBHBS Angels of BostonTETechstars+1 more